Prothena (PRTA)
NASDAQ:PRTA

Prothena (PRTA) Similar Stocks

541 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Apellis Pharmaceuticals
$4.72B
-11.24
21.69%
11 Buy
3 Hold
0 Sell
Strong Buy
$74.69
BioMarin Pharmaceutical
$16.25B
80.10
-1.12%
9 Buy
4 Hold
0 Sell
Moderate Buy
$105.08
Crispr Therapeutics AG
$4.89B
-21.15
0.51%
9 Buy
6 Hold
2 Sell
Moderate Buy
$75.13
FibroGen
$122.35M
-0.50
-34.22%
0 Buy
0 Hold
1 Sell
Moderate Sell
Prothena
$1.33B
-7.62
-60.21%
5 Buy
1 Hold
0 Sell
Strong Buy
$69.83

Performance Comparison

Ticker
Company Name
Price
$ Change
% Change
APLS
Apellis Pharmaceuticals
39.75
7.64
23.79%
BMRN
BioMarin Pharmaceutical
84.59
-1.97
-2.28%
CRSP
Crispr Therapeutics AG
57.92
2.48
4.47%
FGEN
FibroGen
1.16
-0.68
-36.96%
PRTA
Prothena
24.43
-39.68
-61.89%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis